ELOX logo

Eloxx Pharmaceuticals (ELOX) Retained Earnings

Annual Retained Earnings

-$274.39 M
-$36.06 M-15.13%

December 31, 2022


Summary


Performance

ELOX Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherELOXbalance sheetmetrics:

Quarterly Retained Earnings

-$288.55 M
-$3.59 M-1.26%

September 30, 2023


Summary


Performance

ELOX Quarterly Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherELOXbalance sheetmetrics:

Retained Earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

ELOX Retained Earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-15.1%-7.6%
3 y3 years-100.3%-74.4%
5 y5 years-604.3%-235.0%

ELOX Retained Earnings Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-15.1%at low-21.1%at low
5 y5-year-100.3%at low-110.6%at low
alltimeall time<-9999.0%at low<-9999.0%at low

Eloxx Pharmaceuticals Retained Earnings History

DateAnnualQuarterly
Sep 2023
-
-$288.55 M(+1.3%)
Jun 2023
-
-$284.96 M(+1.5%)
Mar 2023
-
-$280.62 M(+2.3%)
Dec 2022
-$274.39 M(+15.1%)
-$274.39 M(+2.4%)
Sep 2022
-
-$268.07 M(+2.9%)
Jun 2022
-
-$260.56 M(+4.2%)
Mar 2022
-
-$249.94 M(+4.9%)
Dec 2021
-$238.32 M(+38.9%)
-$238.32 M(+5.3%)
Sep 2021
-
-$226.23 M(+4.6%)
Jun 2021
-
-$216.35 M(+20.0%)
Mar 2021
-
-$180.29 M(+5.1%)
Dec 2020
-$171.60 M(+25.2%)
-$171.60 M(+3.7%)
Sep 2020
-
-$165.47 M(+4.2%)
Jun 2020
-
-$158.85 M(+5.2%)
Mar 2020
-
-$150.97 M(+10.2%)
Dec 2019
-$137.02 M(+59.1%)
-$137.02 M(+9.3%)
Sep 2019
-
-$125.39 M(+11.4%)
Jun 2019
-
-$112.51 M(+14.7%)
Mar 2019
-
-$98.06 M(+13.8%)
Dec 2018
-$86.14 M(+121.1%)
-$86.14 M(+19.5%)
Sep 2018
-
-$72.12 M(+18.3%)
Jun 2018
-
-$60.96 M(+28.2%)
Mar 2018
-
-$47.55 M(-61.4%)
Dec 2017
-$38.96 M(-68.0%)
-
Sep 2017
-
-$123.21 M(+1.1%)
Jun 2017
-
-$121.82 M(+2.0%)
Jun 2017
-$121.82 M(+5.4%)
-
Mar 2017
-
-$119.45 M(+1.8%)
Dec 2016
-
-$117.38 M(+0.7%)
Sep 2016
-
-$116.57 M(+0.8%)
Jun 2016
-$115.63 M(+7.9%)
-$115.63 M(+1.0%)
Mar 2016
-
-$114.47 M(+2.8%)
Dec 2015
-
-$111.38 M(+3.6%)
Sep 2015
-
-$107.51 M(+0.3%)
Jun 2015
-$107.18 M(+21.4%)
-$107.18 M(+1.6%)
Mar 2015
-
-$105.48 M(+1.2%)
Dec 2014
-
-$104.24 M(+11.5%)
Sep 2014
-
-$93.48 M(+5.9%)
Jun 2014
-$88.28 M(+18.6%)
-$88.28 M(+6.5%)
Mar 2014
-
-$82.90 M(+6.5%)
Dec 2013
-
-$77.87 M(+2.2%)
Sep 2013
-
-$76.23 M(+2.4%)
Jun 2013
-$74.43 M(+10.4%)
-$74.43 M(+2.8%)
Mar 2013
-
-$72.43 M(+1.4%)
Dec 2012
-
-$71.44 M(+1.8%)
Sep 2012
-
-$70.15 M(+4.0%)
Jun 2012
-$67.44 M(+11.0%)
-$67.44 M(+2.4%)
Mar 2012
-
-$65.83 M(+2.3%)
Dec 2011
-
-$64.35 M(+2.6%)
Sep 2011
-
-$62.70 M(+3.2%)
DateAnnualQuarterly
Jun 2011
-$60.75 M(+19.5%)
-$60.75 M(+5.1%)
Mar 2011
-
-$57.80 M(+3.8%)
Dec 2010
-
-$55.68 M(+3.4%)
Sep 2010
-
-$53.86 M(+5.9%)
Jun 2010
-$50.84 M(+41.4%)
-$50.84 M(+32.4%)
Mar 2010
-
-$38.40 M(+16.0%)
Dec 2009
-
-$33.11 M(+5.4%)
Sep 2009
-
-$31.41 M(-12.6%)
Jun 2009
-$35.95 M(+18.9%)
-$35.95 M(+4.6%)
Mar 2009
-
-$34.36 M(+4.0%)
Dec 2008
-
-$33.03 M(+5.2%)
Sep 2008
-
-$31.40 M(+3.9%)
Jun 2008
-$30.22 M(+18.0%)
-$30.22 M(+3.0%)
Mar 2008
-
-$29.34 M(+7.5%)
Dec 2007
-
-$27.30 M(+5.0%)
Sep 2007
-
-$26.00 M(+1.5%)
Jun 2007
-$25.62 M(+14.5%)
-$25.62 M(+2.9%)
Mar 2007
-
-$24.91 M(+3.3%)
Dec 2006
-
-$24.11 M(+4.9%)
Sep 2006
-
-$22.97 M(+2.7%)
Jun 2006
-$22.37 M(+17.4%)
-$22.37 M(+3.6%)
Mar 2006
-
-$21.58 M(+3.4%)
Dec 2005
-
-$20.87 M(+4.6%)
Sep 2005
-
-$19.95 M(+4.7%)
Jun 2005
-$19.05 M(+51.5%)
-$19.05 M(+33.3%)
Mar 2005
-
-$14.29 M(+5.0%)
Dec 2004
-
-$13.61 M(+3.7%)
Sep 2004
-
-$13.13 M(+4.4%)
Jun 2004
-$12.57 M(+32.4%)
-$12.57 M(+3.8%)
Mar 2004
-
-$12.11 M(+3.6%)
Dec 2003
-
-$11.70 M(+7.3%)
Sep 2003
-
-$10.90 M(+14.7%)
Jun 2003
-$9.50 M(+27.8%)
-$9.50 M(+5.2%)
Mar 2003
-
-$9.02 M(+6.1%)
Dec 2002
-
-$8.51 M(+7.1%)
Sep 2002
-
-$7.95 M(+6.9%)
Jun 2002
-$7.43 M(+35.3%)
-$7.43 M(+5.0%)
Mar 2002
-
-$7.08 M(+7.3%)
Dec 2001
-
-$6.60 M(+10.1%)
Sep 2001
-
-$5.99 M(+9.1%)
Jun 2001
-$5.49 M(+51.9%)
-$5.49 M(+8.2%)
Mar 2001
-
-$5.08 M(+9.7%)
Dec 2000
-
-$4.63 M(+12.3%)
Sep 2000
-
-$4.12 M(+14.0%)
Jun 2000
-$3.61 M(+209.1%)
-$3.61 M(+20.8%)
Mar 2000
-
-$2.99 M(+36.0%)
Dec 1999
-
-$2.20 M
Jun 1999
-$1.17 M(+3094.0%)
-
Jun 1998
-$36.60 K(+39.7%)
-
Jun 1997
-$26.20 K
-

FAQ

  • What is Eloxx Pharmaceuticals annual retained earnings?
  • What is the all time high annual retained earnings for Eloxx Pharmaceuticals?
  • What is Eloxx Pharmaceuticals annual retained earnings year-on-year change?
  • What is Eloxx Pharmaceuticals quarterly retained earnings?
  • What is the all time high quarterly retained earnings for Eloxx Pharmaceuticals?
  • What is Eloxx Pharmaceuticals quarterly retained earnings year-on-year change?

What is Eloxx Pharmaceuticals annual retained earnings?

The current annual retained earnings of ELOX is -$274.39 M

What is the all time high annual retained earnings for Eloxx Pharmaceuticals?

Eloxx Pharmaceuticals all-time high annual retained earnings is -$26.20 K

What is Eloxx Pharmaceuticals annual retained earnings year-on-year change?

Over the past year, ELOX annual retained earnings has changed by -$36.06 M (-15.13%)

What is Eloxx Pharmaceuticals quarterly retained earnings?

The current quarterly retained earnings of ELOX is -$288.55 M

What is the all time high quarterly retained earnings for Eloxx Pharmaceuticals?

Eloxx Pharmaceuticals all-time high quarterly retained earnings is -$2.20 M

What is Eloxx Pharmaceuticals quarterly retained earnings year-on-year change?

Over the past year, ELOX quarterly retained earnings has changed by -$20.48 M (-7.64%)